Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-26 · accession 0001055726-22-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-01 | 2022-02-26 | INO | Kim Jong Joseph | CEO, Dir | M - OptEx | — | +68.8K | 1.30M | +6% | — |
| D | 2022-03-01 | 2022-02-26 | INO | Kim Jong Joseph | CEO, Dir | F - Tax | $3.22 | -20.0K | 1.28M | -2% | -$64.5K |
| DM | 2022-03-01 | 2022-02-26 | INO | Kim Jong Joseph | CEO, Dir | A - Grant | $0.00 | +1.10M | 468.5K | New | $0 |
| D | 2022-03-01 | 2022-02-26 | INO | Kim Jong Joseph | CEO, Dir | M - OptEx | $0.00 | -68.8K | 137.5K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-26 | M | A | 68,767 | — | 1,297,425 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 206,300 restricted stock units is as follows: 68,767 shares vested on February 26, 2022; 68,767 shares will vest on February 26, 2023; 68,766 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 2 | Common | Common Stock | 2022-02-26 | F | D | 20,045 | $3.22 | 1,277,380 | D | — | — | |
| 3 | Derivative | Common Stock Option | 2022-02-26 | A | A | 627,700 | $0.00 | 627,700 | D | $3.22 · 2022-02-26 to 2032-02-26 | 627,700 Common Stock | (F3) The vesting schedule for the 627,700 options is as follows: 156,925 shares vested on February 26, 2022; 156,925 shares will vest on February 26, 2023; 156,925 shares will vest on February 26, 2024; 156,925 shares will vest on February 26, 2025. |
| 4 | Derivative | Restricted Stock Unit | 2022-02-26 | M | D | 68,767 | $0.00 | 137,533 | D | — · — to — | 68,767 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 206,300 restricted stock units is as follows: 68,767 shares vested on February 26, 2022; 68,767 shares will vest on February 26, 2023; 68,766 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 5 | Derivative | Restricted Stock Unit | 2022-02-26 | A | A | 468,500 | $0.00 | 468,500 | D | — · — to — | 468,500 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 468,500 restricted stock units is as follows: 156,167 shares will vest on February 26, 2023; 156,167 shares will vest on February 26, 2024; 156,166 shares will vest on February 26, 2025. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both. |